Qualitative analysis reveals proliferation risks in Kazakhstan, Uzbekistan, and Türkiye, suggesting enhanced regional cooperation as a solution.
Objectives This study investigates the nuclear legacies, current developments, and proliferation risks in three Turkic states: Kazakhstan, Uzbekistan, and Türkiye. While these countries have not been central to global non-proliferation debates, recent geopolitical shifts, regional instability, and rising interest in nuclear energy have increased their relevance. The research explores each state's nuclear ambitions—driven by security concerns, economic goals, and geopolitical positioning—and outlines proliferation-related threats in these countries while offering actionable solutions to mitigate them. Methods The research is based on a qualitative, document-based approach. It analyses open-source materials such as reports from international organizations (e.g., the IAEA), government policy papers, and publications from respected think tanks. The focus is on each country’s nuclear history, current policy trajectory, and the broader strategic context affecting proliferation risks. Results Kazakhstan and Uzbekistan, as major uranium producers, face risks primarily associated with material security and regulatory oversight. Türkiye, although lacking large uranium reserves, poses distinct challenges due to its expanding civilian nuclear program and strong political ambitions to become dominating power in the region. The study identifies that recent dynamics in global order destabilize security environment within and around Turkic States, which may cause intensification of arms race. Currently there are no sufficient international, oversight mechanisms to control it. Conclusions The paper recommends improved regional cooperation and the establishment of a dedicated nuclear supervising body under the Organization of Turkic States (OTS). Such a framework would promote transparency, mitigate proliferation risks, and ensure that nuclear developments in the region align with peaceful and internationally accepted standards
No takes yet. Share an insight, caveat, or question.
Eryk Marchlewski (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: